6 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 1 / Phase 22026-10-09NCT05326243
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)Group 3 Pulmonary HypertensionRecruitingPhase 22026-09-21NCT06475781
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 22026-09-01NCT05304481
Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease ScreeningDiabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, retinal degeneration, retinal disorder, vascular disorderRecruitingNot applicable2026-07-22NCT06843499
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical DysplasiaFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, cervical intraepithelial neoplasia grade 2/3, cervix disorder, dysplasia of cervix, female reproductive system disorder, neoplasm, precancerous condition, uterine disorderRecruitingPhase 22026-05-06NCT07454915
AI-Assisted Chest X-Ray for Misplaced Endotracheal and Nasogastric Tubes and Pneumothorax in Emergency and Critical Care Settingspleural disorder, pneumothorax, respiratory system disorderNot yet recruitingNot applicable2026-03-17NCT06842043